Quantel and its subsidiaries are engaged in the production, development and distribution of lasers for medical applications mainly in ophthalmology and dermatology. Co. produces lasers for scientific instrumentation involved in research and development and underwater lasers. Co. also provides laser impulses for industrial applications such as laser cleaning or material processing.
  • TickerQUA
  • ISINFR0000038242
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

Pierre Buon

LUMIBIRD. CE marking approval for the LacrySTIM IPL (+)

LUMIBIRD. CE marking approval for the LacrySTIM IPL (+)

Charles Louis Planade ...
  • Pierre Buon

LUMIBIRD. Obtention du marquage CE pour LacrySTIM IPL

LUMIBIRD. Obtention du marquage CE pour LacrySTIM IPL

Pierre Buon

Conference Feedback Midcap Partners. LUMIBIRD

Conference Feedback Midcap Partners. LUMIBIRD

Pierre Buon

LUMIBIRD. Capital increase

LUMIBIRD. Capital increase

Pierre Buon

LUMIBIRD. CE marking approval for the LacrySTIM IPL (+)

LUMIBIRD. CE marking approval for the LacrySTIM IPL (+)

Charles Louis Planade ...
  • Pierre Buon

LUMIBIRD. Obtention du marquage CE pour LacrySTIM IPL

LUMIBIRD. Obtention du marquage CE pour LacrySTIM IPL

Pierre Buon

Conference Feedback Midcap Partners. LUMIBIRD

Conference Feedback Midcap Partners. LUMIBIRD

Pierre Buon

LUMIBIRD. Capital increase

LUMIBIRD. Capital increase

Pierre Buon

LUMIBIRD :Augmentation de capital

LUMIBIRD :Augmentation de capital

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Lumibird (ex Quantel) - Assemblée Générale des actionnaires du 24 mai 2019

Bien que la société présente bien une politique de rémunération pour 2019, celle-ci ne comprend aucune information précise concernant les montants ou structure en jeu, ce qui ne permet pas à l’actionnaire de se faire une idée précise de la politique qu’il est censé approuver. Au regard de ce manque de transparence, nous ne pouvons pas soutenir la résolution 6. Par ailleurs, la société n'exclut pas de pouvoir mettre en oeuvre ses diverses délégations financières en période d'offre publique, ce qui en fait de potentielles dispositifs anti-OPA. Nous ne les soutenons donc pas.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch